Company Filing History:
Years Active: 2016
Title: Luis Martin-Parras: Innovator in Human Cytomegalovirus Treatment
Introduction
Luis Martin-Parras is a notable inventor based in Jena, Germany. He has made significant contributions to the field of medical research, particularly in the area of human cytomegalovirus (hCMV) treatment. His innovative work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
Luis Martin-Parras holds a patent for "Binding members for human cytomegalovirus." This invention relates to binding members, especially antibody molecules, that can neutralize the biological effects of hCMV. The binding members developed by Martin-Parras may be useful for both the treatment and prophylaxis of hCMV infection. He has 1 patent to his name.
Career Highlights
Luis is currently associated with 4-Antibody AG, a company focused on developing therapeutic antibodies. His work at the company has allowed him to further his research and contribute to advancements in the treatment of viral infections.
Collaborations
Throughout his career, Luis has collaborated with esteemed colleagues such as Ulf Grawunder and Michael Mach. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field.
Conclusion
Luis Martin-Parras is a dedicated inventor whose work in the realm of human cytomegalovirus treatment showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options that could benefit many patients in the future.